Group 1 - The core point of the article is the successful approval and registration of Suzhou Fengbei Biotechnology Co., Ltd.'s initial public offering (IPO) of A-shares on the Shanghai Stock Exchange, with the underwriting by Guotai Junan Securities Co., Ltd. [1] - The total number of shares for this issuance is set at 35.9 million, with an initial strategic placement of 7.18 million shares, accounting for 20% of the total issuance [2] - The final strategic placement was adjusted to 4.083297 million shares, which is 11.37% of the total issuance, with the difference being allocated to offline issuance [2] Group 2 - The issuance price is set at 24.49 yuan per share, with the online offering of 11.488 million shares scheduled for October 27, 2025 [2] - The initial effective subscription multiple for the online offering was 8,814.92 times, leading to the activation of a mechanism to adjust the allocation between offline and online offerings [3] - After the adjustment, the final allocation resulted in 760,170.3 thousand shares for offline issuance and 2,421,500 shares for online issuance, with the online issuance accounting for 76.11% of the adjusted total [3] Group 3 - Investors are required to fulfill their payment obligations by October 29, 2025, with specific instructions for both offline and online investors regarding the payment process [4] - If the total number of shares subscribed by offline and online investors does not meet 70% of the adjusted total issuance, the offering will be suspended [5] - There are restrictions on the resale of 10% of the shares allocated to offline investors for a period of six months from the date of listing [5] Group 4 - The strategic placement process has concluded successfully, with all participating investors fulfilling their payment commitments by the specified deadline [8] - The final results of the strategic placement and the online lottery for shares will be announced following the draw on October 28, 2025 [10][11] - The offline issuance saw a total of 7,490,110 thousand shares subscribed, with the initial allocation process adhering to the announced guidelines [12][13]
苏州丰倍生物科技股份有限公司首次公开发行股票并在主板上市网下初步配售结果及网上中签结果公告
Shang Hai Zheng Quan Bao·2025-10-28 20:57